STAT3 and hepatocellular carcinoma: XZH-5 and analogues are other examples of small compounds designed to recognize the SH2 domain of STAT3 to inhibit its phosphorylation and subsequently induce cell death in hepatocellular carcinoma and breast cancer cells [147,148].